Prescription Technology Solutions — Goodwill
McKesson Prescription Technology Solutions — Goodwill remained flat by 0.0% to $2.07B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $2.02B to $2.07B. Over 4 years (FY 2021 to FY 2025), Prescription Technology Solutions — Goodwill shows an upward trend with a 7.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
A stable or growing balance reflects historical M&A activity, while a sudden decrease indicates an impairment charge, signaling potential overpayment for past acquisitions.
Detailed definition
Represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinat...
Peer comparison
Standard balance sheet item for any company that has grown through acquisitions, common across the pharmaceutical distribution industry.
mck_segment_prescription_technology_solutions_goodwillHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.54B | $1.54B | $1.54B | $1.54B | $1.54B | $1.54B | $2.01B | $2.01B | $2.01B | $2.01B | $2.01B | $2.02B | $2.02B | $2.02B | $2.02B | $2.03B | $2.07B | $2.07B | $2.07B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +30.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.9% | +0.0% | +0.0% | +0.0% | +0.1% | +1.9% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +30.0% | +30.0% | +30.0% | +30.0% | +0.0% | +0.9% | +0.9% | +0.9% | +0.9% | +0.1% | +2.1% | +2.1% | +2.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — goodwill?
- McKesson (MCK) reported prescription technology solutions — goodwill of $2.07B in Q4 2025.
- How has McKesson's prescription technology solutions — goodwill changed year-over-year?
- McKesson's prescription technology solutions — goodwill increased by 2.1% year-over-year, from $2.02B to $2.07B.
- What is the long-term trend for McKesson's prescription technology solutions — goodwill?
- Over 4 years (2021 to 2025), McKesson's prescription technology solutions — goodwill has grown at a 7.5% compound annual growth rate (CAGR), from $6.17B to $8.23B.
- What does prescription technology solutions — goodwill mean?
- The value of intangible assets like brand and market position acquired through past business purchases in the technology solutions segment.